0 0 0 0 -0.00215499378367182 -0.00273518441773724 -0.00232076253626192 -0.0017405719021965
Sign Up Today X
Thanks for submitting the form.
Stockreport

UBS and Citi Go Bullish on Gilead Sciences (GILD) [Yahoo! Finance]

Gilead Sciences, Inc. (GILD)  More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
On January 7, 2026, reports highlighted that analysts are increasingly confident in Gilead Sciences, Inc. (NASDAQ:GILD)'s short- and medium-term outlook, driven by optimism around the company's HIV franchise. On that day, UBS analyst Michael Yee upgraded the stock from ‘Neutral' to ‘Buy' and raised the firm's price target from $112 to $145, according to The Fly. The analyst expects strong HIV pre-exposure prophylaxis sales from Yeztugo, which could potentially boost both revenue and earnings. At the same time, the analyst expects visibility into the company's outer-year growth trajectory to improve. Furthermore, Yee highlighted the company's focus on prevention-based HIV therapies, which reflects a strategic evolution of the company's core antiviral business toward more durable, growth-oriented demand drivers. This positive update was accompanied by another on the same day, with Citi's analyst Geoff Meacham raising the firm's target from $135 to $140 and maintaining a ‘Buy' rating. [Read more]
IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GILD alerts
from News Quantified
GILD
NEWS
GILD
Earnings
GILD
Analyst Actions
GILD
SEC Filings
Stockreport

UBS and Citi Go Bullish on Gilead Sciences (GILD) [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
More Company Research Source: Yahoo! Finance
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
On January 7, 2026, reports highlighted that analysts are increasingly confident in Gilead Sciences, Inc. (NASDAQ:GILD)'s short- and medium-term outlook, driven by optimism around the company's HIV franchise. On that day, UBS analyst Michael Yee upgraded the stock from ‘Neutral' to ‘Buy' and raised the firm's price target from $112 to $145, according to The Fly. The analyst expects strong HIV pre-exposure prophylaxis sales from Yeztugo, which could potentially boost both revenue and earnings. At the same time, the analyst expects visibility into the company's outer-year growth trajectory to improve. Furthermore, Yee highlighted the company's focus on prevention-based HIV therapies, which reflects a strategic evolution of the company's core antiviral business toward more durable, growth-oriented demand drivers. This positive update was accompanied by another on the same day, with Citi's analyst Geoff Meacham raising the firm's target from $135 to $140 and maintaining a ‘Buy' rating. [Read more]
IMPACT SNAPSHOT
EVENT TIME:
GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS